Proven PRRS Solutions
Elanco offers both an effective vaccine against porcine reproductive and respiratory syndrome (PRRS) and an antimicrobial solution for SRD associated with M. hyo in the presence of PRRS.
Your PRRS Mitigation Protocol
Talk to your Elanco representative about updating your PRRS protocol today.
Prevacent® PRRS - 20 dose
Prevacent® PRRS has proven effective against the respiratory form of PRRS in healthy pigs at least 2 weeks of age or older and against reproductive disease when vaccinated 6 weeks prior to breeding.
Prevacent® PRRS - 100 dose
Prevacent® PRRS has proven effective against the respiratory form of PRRS in healthy pigs at least 2 weeks of age or older and against reproductive disease when vaccinated 6 weeks prior to breeding.
Prevacent® PRRS - 250 dose
Prevacent® PRRS has proven effective against the respiratory form of PRRS in healthy pigs at least 2 weeks of age or older and against reproductive disease when vaccinated 6 weeks prior to breeding.
Pulmotil® AC (tilmicosin phosphate)
Pulmotil® AC quickly and effectively controls SRD associated with M. hyo in the presence of PRRS without the need to formulate new rations, or invest the additional time, individual documentation and repeated injection associated with individual pig injections.
The label contains complete use information, including cautions and warnings. Always read, follow and understand the label and use directions.
Pulmotil® AC
IMPORTANT SAFETY INFORMATION:
Before using this product, it is important to read the entire product insert, including the boxed human warning.
WARNING: Exposure to tilmicosin in humans has been associated with chest pain, increased heart rate, dizziness, headache, and nausea. Death has been reported following ingestion or injection of tilmicosin. Avoid direct skin and eye contact. In case of human exposure, call 1-800-722-0987 and consult a physician immediately.
- Wear overalls, impervious gloves and eye protection when mixing and handling the product. Wash hands after handling the product. Wash affected parts if skin contact occurs. If accidental eye contact occurs, immediately rinse thoroughly with water.
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- For use only in swine. Not for injection. Injection of tilmicosin has been shown to be fatal in swine and non-human primates, and may be fatal in horses and goats.
- Swine intended for human consumption must not be slaughtered within 7 days of treatment.
- Always treat the fewest number of animals necessary to control a respiratory disease outbreak. Prescriptions shall not be refilled.
- Concurrent use of Pulmotil AC and another macrolide by any route, or use of another macrolide immediately following this use of Pulmotil AC is not advised.
- Ensure that pigs have continuous access to medicated water during the treatment period. Monitor pigs for signs of water refusal and dehydration while being treated.
INDICATIONS:
- For the control of swine respiratory disease associated with Pasteurella multocida and Haemophilus parasuis.
- For the control of swine respiratory disease associated with Mycoplasma hyopneumoniae in the presence of porcine reproductive and respiratory syndrome virus (PRRSv) in groups of swine in buildings where a respiratory disease outbreak is diagnosed.
DOSAGE AND ADMINISTRATION:
- Must be diluted before administration to animals.
- Include in the drinking water to provide a concentration of 200 mg tilmicosin per liter (200 ppm).
- One 960 ml bottle is sufficient to medicate 1200 liters (320 gallons) of drinking water for pigs.
- The medicated water should be administered for (5) five consecutive days.
- Use within 24 hours of mixing with water.
- Do not use rusty containers for medicated water as they may affect product integrity.
- When using a water medicating pump with a 1:128 inclusion rate, add 1 bottle (960 ml) of Pulmotil AC per 2.5 gallons of stock solution.
Prevacent® PRRS
INDICATIONS:
- This product has been shown to be effective for the vaccination of healthy pigs 2 weeks of age or older against PRRS respiratory disease; and against reproductive disease when vaccinated 6 weeks prior to breeding.
- The duration of immunity against respiratory disease is at least 26 weeks.
- The duration of immunity against reproductive disease has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
- Safety of this product has been demonstrated when sows or gilts are vaccinated prior to breeding or at any stage of pregnancy.
- Vaccine virus may be shed and transmitted to other populations of swine in contact with vaccinated swine.
- The duration of potential vaccine virus transmission may vary.
- Use of the vaccine in herds intended to remain PRRS virus seronegative is contraindicated.
- Introduction of vaccinated pigs into herds intended to remain PRRS virus seronegative is contraindicated.
DOSAGE AND ADMINISTRATION:
- Rehydrate with the accompanying sterile diluent.
- Shake well and draw back into the syringe the required amount.
- Administer 1 mL intramuscularly.
- The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.
IMPORTANT SAFETY INFORMATION
PRECAUTIONS:
- Store at 2°- 8°C (35°- 46°F). DO NOT FREEZE.
- Use entire contents when first opened.
- Do not mix with other products, except as specified on this label. In case of human exposure, contact a physician.
- Do not vaccinate within 21 days before slaughter.
- Inactivate unused contents before disposal.
- Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains gentamicin as preservative.
